MDT and patient caregiver perspectives on emerging agents for TSC-associated seizures episode artwork

EPISODE · Dec 8, 2022 · 12 MIN

MDT and patient caregiver perspectives on emerging agents for TSC-associated seizures

from touchPODCAST · host touchpodcast

touchMDT for touchNEUROLOGY Listen to key experts from a multidisciplinary team, plus a caregiver for a patient with TSC, discuss emerging agents for the treatment of patients with TSC-associated seizures and the potential they hold for improving patient outcomes The multidisciplinary team: Paediatric neurologist and epilepsy specialist: Prof. James Wheless, Tennessee, USA Epilepsy specialist: Prof. Katarzyna Kotulska, Warsaw, Poland Patient caregiver: Ms Lisa Moss, Maryland, USA This touchPODCAST is for HCPs only.  This activity is funded by an independent medical education grant from Jazz Pharmaceuticals. This activity is jointly provided by USF Health and touchIME. For further information visit our website:  https://touchneurology.com/cme/mdt-improving-outcomes-in-tuberous-sclerosis-complex-associated-seizures/# 

Episode metadata supplied by the publisher feed · Published Dec 8, 2022

Embed this episode

Ready to play

MDT and patient caregiver perspectives on emerging agents for TSC-associated seizures

0:00 12:34

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of touchPODCAST?

This episode is 12 minutes long.

When was this touchPODCAST episode published?

This episode was published on December 8, 2022.

Can I download this touchPODCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!